An essential resource for R&D professionals and clinicians with an interest in biologic therapies.
BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease.
BioDrugs offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.
In-Use Stability of the Rituximab Biosimilar CT-P10 (Truxima®) Following Preparation for Intravenous Infusion and Storage
Letter to the Editor
Sarfaraz K. Niazi (February 2019)
Adis Biosimilar Brief
Sheridan M. Hoy (February 2019)
- Journal Title
- Volume 1 / 1994 - Volume 33 / 2019
- Print ISSN
- Online ISSN
- Springer International Publishing
- Additional Links
- Industry Sectors
|Previous Title||Print ISSN||Online ISSN|
To view the rest of this content please follow the download PDF link above.